Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Emergency department leadership considerations for the next phase of the COVID-19 pandemic.
Rosenberg, Hans; Snider, Carolyn; Schull, Michael J; Ovens, Howard; Lang, Eddy.
CJEM ; 25(2): 110-114, 2023 02.
Article in English | MEDLINE | ID: covidwho-2209623

Subject(s)
COVID-19 , Humans , COVID-19/epidemiology , Leadership , Pandemics , SARS-CoV-2 , Emergency Service, Hospital
2.
Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS randomized clinical trial.
Durr, Kevin M; Yadav, Krishan; Rosenberg, Hans.
CJEM ; 24(6): 582-584, 2022 09.
Article in English | MEDLINE | ID: covidwho-1878019

Subject(s)
COVID-19 , Noninvasive Ventilation , Respiratory Insufficiency , COVID-19/therapy , Humans , Intubation, Intratracheal , Respiratory Insufficiency/therapy
3.
Is inhaled budesonide an effective treatment for patients with mild early symptoms of COVID-19?
Kareemi, Hashim; Rosenberg, Hans; Yadav, Krishan.
CJEM ; 23(5): 611-612, 2021 09.
Article in English | MEDLINE | ID: covidwho-1316357

Subject(s)
Budesonide , COVID-19 , Administration, Inhalation , Bronchodilator Agents/therapeutic use , Humans , SARS-CoV-2
4.
Just the facts: updates in COVID-19 therapeutics.
Long, Brit; Liang, Stephen Y; Rosenberg, Hans; Hicks, Christopher; Gottlieb, Michael.
CJEM ; 23(3): 283-285, 2021 05.
Article in English | MEDLINE | ID: covidwho-1068844

Subject(s)
Antiviral Agents/therapeutic use , COVID-19 Drug Treatment , SARS-CoV-2 , COVID-19/epidemiology , Global Health , Humans , Pandemics , Randomized Controlled Trials as Topic , Survival Rate/trends
5.
New challenges and mitigation strategies for resident selection during the coronavirus disease pandemic.
Rosenberg, Hans; Nath, Avik; Leppard, Jennifer; Syed, Shahbaz.
CJEM ; 22(6): E14, 2020 11.
Article in English | MEDLINE | ID: covidwho-857324

Subject(s)
COVID-19/epidemiology , Internship and Residency , Personnel Selection/organization & administration , Canada/epidemiology , Humans , Pandemics , SARS-CoV-2
6.
Authentic emergency department leadership during a pandemic.
Lang, Eddy; Ovens, Howard; Schull, Michael J; Rosenberg, Hans; Snider, Carolyn.
CJEM ; 22(4): 400-403, 2020 07.
Article in English | MEDLINE | ID: covidwho-693080

Subject(s)
Coronavirus Infections/epidemiology , Emergency Service, Hospital/organization & administration , Infection Control/organization & administration , Leadership , Patient Care Team/organization & administration , Pneumonia, Viral/epidemiology , Betacoronavirus , COVID-19 , Humans , Pandemics , SARS-CoV-2
7.
Resident learning during a pandemic: Recommendations for training programs.
Mok, Garrick; Schouela, Nicholas; Thurgur, Lisa; Ho, Michael; Hall, Andrew K; Jaelyn, Caudle; Rosenberg, Hans; Syed, Shahbaz.
CJEM ; 22(5): 617-621, 2020 Jun 29.
Article in English | MEDLINE | ID: covidwho-677759
8.
Just the facts: What drugs are safe and effective for COVID-19?
Long, Brit; Liang, Stephen Y; Rosenberg, Hans; Hicks, Christopher; Gottlieb, Michael.
CJEM ; 22(5): 591-594, 2020 09.
Article in English | MEDLINE | ID: covidwho-326701

ABSTRACT

A 53-year-old male presents with cough, fever, and myalgias for 7 days. Vitals include temperature, 38.0°C; heart rate, 110; blood pressure, 118/70 mm Hg; respiration rate, 28; and oxygen saturation 83% on room air. His only past medical history is hypertension. Your community is in the midst of the coronavirus disease 2019 (COVID-19) pandemic. The patient is hypoxic but responds to oxygen supplementation with nasal cannula and a face mask. His chest x-ray demonstrates multifocal infiltrates. Are there any therapeutic agents currently available for COVID-19?


Subject(s)
Adenosine Monophosphate/analogs & derivatives , Alanine/analogs & derivatives , Coronavirus Infections/drug therapy , Drug Therapy/methods , Pneumonia, Viral/drug therapy , Severe Acute Respiratory Syndrome/drug therapy , Adenosine Monophosphate/administration & dosage , Alanine/administration & dosage , Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Antimalarials/administration & dosage , Antimalarials/pharmacology , Antiviral Agents/administration & dosage , Antiviral Agents/pharmacology , COVID-19 , Coronavirus Infections/epidemiology , Humans , Male , Middle Aged , Needs Assessment , Pandemics , Patient Safety , Pneumonia, Viral/epidemiology , Risk Assessment , Severe Acute Respiratory Syndrome/diagnosis , Severity of Illness Index , Steroids/administration & dosage , Steroids/pharmacology , Treatment Outcome
9.
The Twitter pandemic: The critical role of Twitter in the dissemination of medical information and misinformation during the COVID-19 pandemic.
Rosenberg, Hans; Syed, Shahbaz; Rezaie, Salim.
CJEM ; 22(4): 418-421, 2020 07.
Article in English | MEDLINE | ID: covidwho-30698

Subject(s)
Coronavirus Infections/epidemiology , Information Dissemination , Pneumonia, Viral/epidemiology , Social Media , Betacoronavirus , COVID-19 , Communication , Humans , Pandemics , SARS-CoV-2
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL